Prot# M02-537: A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients with Moderate to Severely Active Psoriatic Arthritis

Project: Research project

Project Details

StatusFinished
Effective start/end date9/24/039/11/10

Funding

  • PPD Development (M02-537)
  • Abbott Laboratories (M02-537)